Selective GHS-R1a agonist
Minimal cortisol/prolactin off-target in models.
FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from peer-reviewed literature for educational reference.
Secretagogue Peptide
Ipamorelin
- NNC 26-0161
CAS: 170851-70-4
A selective pentapeptide ghrelin-receptor agonist studied in research models of GH-axis activation with minimal effect on cortisol or prolactin pathways.
CoA available on request
- Free shipment protection
- Free shipping on $250+
- Damage protection
- 256-bit SSL checkout
Pentapeptide
5-AA structure — fast onset and clearance.
99%+ identity purity
HPLC + MS verified per batch. CoA included.
What Is Ipamorelin?
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) acting as a selective agonist at the growth-hormone secretagogue receptor (GHS-R1a). In preclinical studies it produces GH release without the cortisol or prolactin elevation observed with earlier-generation secretagogues, making it a frequent reference compound in GH-pulsatility research.
Technical specifications
Type
Synthetic pentapeptide (GHS-R1a agonist)
Formula
C₃₈H₄₉N₉O₅
Molecular weight
711.85 g/mol
CAS number
170851-70-4
Appearance
White lyophilized powder
Identity purity
≥ 99% (HPLC + MS)
Peer-reviewed research
- Eur J EndocrinolIpamorelin, the first selective growth hormone secretagogue
- J EndocrinolCombined administration of GHRH and a GHRP synergistically stimulates GH release
Frequently researched together
IMPORTANT RESEARCH NOTICE
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.